Consequences of drug abuse and HIV/AIDS in China: recommendations for integrated care of HIV-infected drug users.
Drug abuse is a complicated social phenomenon rather than a neural disease. It especially fuels the HIV/AIDS epidemic. Researchers have shown interest in HIV-infected drug users as the socially and medically marginalized population, but they did not provide good enough care. Based on published English and Chinese journal articles and official reports, this integrated literature review summarizes the epidemic of drug abuse and HIV/AIDS, and comments on the clinical and psychosocial consequences, and harm reduction measures in China. Officially registered drug users have reached more than 1 million recently. A little under half of the people living with HIV/AIDS are injection drug users, as they transmit the disease through needle sharing and unprotected sexual behavior. The main consequences of drug abuse and HIV/AIDS included high prevalence of hepatitis viruses and tuberculosis co-infections, severe mental problems and extreme poverty. Even health professionals hold discriminative attitude toward drug users because of condemnation of drug abuse behavior and fear of HIV infection. Although interventions for drug addiction and harm reduction have been scaled up quickly, such as methadone maintenance treatment and needle syringe programs, the measures should be further revised, and the effectiveness needs to be evaluated appropriately. To enhance HIV-infected drug users' quality of life and the utility of medical services, improving health care providers' attitude is the first step. Then securing good quality of integrated medical care services with multidisciplinary cooperation will be essential.
Li
Xianhong
X
School of Nursing, Central South University, Changsha, China.
He
Guoping
G
Wang
Honghong
H
Williams
Ann Bartley
AB
D002681:China / Q000453:epidemiology; D019033:Delivery of Health Care, Integrated / Q000191:economics; D015658:HIV Infections / Q000150:complications* / Q000453:epidemiology / Q000628:therapy; D006801:Humans; D015995:Prevalence; D012944:Social Support; D013240:Stereotyping; D019966:Substance-Related Disorders / Q000150:complications* / Q000453:epidemiology / Q000628:therapy; D016896:Treatment Outcome